UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND

Abstract

The present invention relates to a UV blocking composition comprising red algae-derived floridoside and an amine group-containing compound, and a use thereof in a cosmetic material and a pharmaceutical composition.

Claims

1. A UV blocking composition containing red algae-derived floridoside and an amine group-containing compound.

2. The composition of claim 1, wherein the red algae-derived floridoside includes red algae-derived glycerol galactoside, red algae-derived glycerol glucoside, or both thereof.

3. The composition of claim 2, wherein the red algae-derived glycerol galactoside is floridoside represented by chemical formula 1, or a salt or isomer thereof: ##STR00003##

4. The composition of claim 2, wherein the red algae-derived glycerol galactoside is isofloridoside represented by chemical formula 2, or a salt or isomer thereof: ##STR00004##

5. The composition of claim 1, wherein the amine group-containing compound is at least one selected from the group consisting of a nucleobase, a nucleoside, and an amino acid.

6. The composition of claim 1, wherein the red algae-derived floridoside and the amine group-containing compound form a covalent bond.

7. The composition of claim 1, wherein the red algae-derived floridoside is alkylated by the amine group-containing compound.

8. The composition of claim 5, wherein the nucleobase is at least one selected from adenine, guanine, cytosine, thymine, and uracil.

9. The composition of claim 5, wherein the nucleoside includes a ribonucleoside, a deoxyribonucleoside, or both thereof.

10. The composition of claim 1, wherein the red algae-derived floridoside and the amine group-containing compound form a glycoside covalent derivative.

11. A UV blocking cosmetic composition comprising the composition of claim 1.

12. A UV blocking pharmaceutical composition comprising the composition of claim 1.

Description

BRIEF DESCRIPTION OF DRAWINGS

[0017] FIG. 1 is a graph obtained by measurement of UV absorption performance of floridoside according to an embodiment of the present invention.

[0018] FIG. 2 illustrates a .sup.1H-NMR graph of floridoside according to an embodiment of the present disclosure.

[0019] FIG. 3 illustrates a .sup.13C-NMR graph of floridoside according to an embodiment of the present disclosure.

[0020] FIGS. 4 and 5 illustrate mass spectrum graphs of floridoside according to an embodiment of the present disclosure.

[0021] FIG. 6 is a graph obtained by measurement of UV absorption performance of a glycoside covalent derivative of floridoside and a nucleobase according to an embodiment of the present disclosure.

[0022] FIG. 7 is a graph obtained by measurement of UV absorption performance of a glycoside covalent derivative of floridoside and a nucleoside according to an embodiment of the present disclosure.

[0023] FIGS. 8 and 9 are graphs obtained by measurement of UV absorption performance of a glycoside covalent derivative of floridoside and an amino acid according to an embodiment of the present disclosure.

BEST MODE FOR CARRYING OUT THE INVENTION

[0024] Hereinafter, the present disclosure will be described in detail.

[0025] An embodiment of the present disclosure is directed to a UV blocking composition containing red algae-derived floridoside and an amine group-containing compound.

[0026] In the present disclosure, the red algae may include the class Bangiophyceae, the class Compsopogonophyceae, or the class Florideophyceae. The class Bangiophyceae preferably includes the order Bangiales, but is not particularly limited thereto. The class Florideophyceae preferably includes the order Ceramiales, the order Corallinales, the order Gelidiales, the order Gracilariales, the order Halymeniale, the order Nemaliales, the order Nemastomatales, the order Palmariales, or the order Stylonematales, but is not particularly limited thereto.

[0027] The floridoside is a low-molecular weight carbohydrate stored in cells of red alga and a kind of galactose glycoside. Floridoside has an average mass of 254.234 Da, a monoisotopic mass of 254.100174 Da, and a molecular formula of C.sub.9H.sub.18O.sub.8. Floridoside is also called 2-O-glycerol-α-D-galactopyranoside or 2-O-α-D-galactopyranosylglycerol.

[0028] According to an embodiment of the present disclosure, the red algae-derived floridoside may be red algae-derived glycerol galactoside and/or red algae-derived glycerol glucoside.

[0029] A galactoside is a glycoside having galactose as a sugar component and is a compound in which hydrogen of the hydroxy group on carbon-1 of galactose is replaced by an organic moiety. There are a-galactosides and β-galactosides according to the bonding configuration.

[0030] The glycerol galactoside may be floridoside represented by Chemical Formula 1, or a salt or isomer thereof.

##STR00001##

[0031] Alternatively, the glycerol galactoside may be isofloridoside represented by Chemical Formula 2, or a salt or isomer thereof.

##STR00002##

[0032] The isofloridoside is also called 1-O-glycerol-α-D-galactopyranoside.

[0033] The floridoside and isofloridoside are preferably derived from red algae.

[0034] According to an embodiment of the present disclosure, the UV blocking composition may be one in which red algae-derived floridoside is (covalently) bound or mixed with an amine group-containing compound.

[0035] Specifically, the UV blocking composition may be one in which red algae-derived floridoside is alkylated by an amine group-containing compound.

[0036] The amine group-containing compound may be at least one selected from the group consisting of a nucleobase, a nucleoside, and an amino acid.

[0037] The nucleobase may be at least one selected from adenine, guanine, cytosine, thymine, and uracil. In addition, the nucleoside may be a ribonucleoside or a deoxyribonucleoside.

[0038] An embodiment of the present disclosure is directed to a composition formed by covalently binding or mixing red algae-derived floridoside and an amine group-containing compound, and exhibits an excellent UV blocking and preventing effect.

[0039] Preferably, the UV blocking composition includes a glycoside covalent derivative of red algae-derived floridoside and an amine group-containing compound.

[0040] According to an embodiment of the present disclosure, the UV blocking composition may include a glycoside covalent derivative of red algae-derived floridoside and a nucleobase.

[0041] According to another embodiment of the present disclosure, the UV blocking composition may include a glycoside covalent derivative of red algae-derived floridoside and a nucleoside.

[0042] According to still another embodiment of the present disclosure, the UV blocking composition may include a glycoside covalent derivative of red algae-derived floridoside and an amino acid.

[0043] A UV blocking cosmetic composition according to an embodiment of the present disclosure has UV absorption performance and is surprisingly found to have excellent ability to absorb wavelengths over a wide UV region of 280-400 nm including both UV B (290˜320 nm) and UV A(320˜400 nm).

[0044] Therefore, the cosmetic composition according to the embodiment of the present disclosure may be used as a naturally derived UV blocker or as a composition that helps UV absorption.

[0045] In particular, a covalent derivative of red algae-derived floridoside and a nucleobase, a nucleoside, or an amino acid, which are contained in a composition according to an embodiment of the present disclosure, is well dissolved in water, safe against heat and light, free from toxicity to cause no irritation to the skin, and exhibits a feature of absorbing a UV range of 280-400 nm, leading to a remarkable effect in blocking UV A and B. As shown in FIGS. 6 to 9, the glycoside covalent derivatives of red algae-derived floridoside and a nucleobase, a nucleoside, or an amino acid had excellent ability to absorb wavelengths over the broad UV entire range of 280-400 nm.

[0046] In an embodiment of the present disclosure, the UV blocking cosmetic composition preferably contains 1-30 wt % of the glycoside covalent derivative of red algae-derived floridoside and a nucleobase, a nucleoside, or an amino acid.

[0047] A UV blocking cosmetic composition according to an embodiment of the present disclosure preferably blocks blue light. The blue light blocking effect is particularly meaningful since blue light penetrates to the deepest site of the skin.

MODE FOR CARRYING OUT THE INVENTION

[0048] Hereinafter, the present invention will be described in more detail with reference to exemplary embodiments. These exemplary embodiments are provided only for the purpose of illustrating the present disclosure in more detail, and therefore, according to the purpose of the present disclosure, it would be apparent to a person skilled in the art that these examples are not construed to limit the scope of the present disclosure.

Preparative Example 1: Preparation of Floridoside

[0049] Gracilaria vermiculophylla (a kind of red algae) was collected in Jangheung and Wando island, South Jeolla Province, Korea, and then subjected to room-temperature extraction using a mixture solvent containing ethanol and methanol for 24 hours, followed by hot-water extraction for 6 hours. The extract was concentrated by removing salts and polysaccharides through filtration, and subjected to repeated fractionation and purification to obtain 95% or more of a floridoside powder of 254 Dal, which was then diluted with distilled water.

[0050] The obtained material was purified through the HILIC column, thereby finally obtaining a sample with 99% or more of floridoside. To investigate whether the obtained sample was floridoside, structure analysis was performed using the following materials and reagents.

[0051] Preparative-liquid chromatography (prep-LC) (LC-Forte/R, YMC, Japan)

[0052] Venusil Hilic (21.2×250 mm, 5 □m, Agela, USA)

[0053] VisionHT Hilic (4.6×250 mm, 5 □m, Grace, USA)

[0054] Kiesel gel 60F254 plate (Merck Co., Darmastdt, Germany)

[0055] RP-18° F.254s plates (Merck Co., Darmastdt, Germany)

[0056] Bruker AVANCE II 400 (1H NMR at 400 MHz, 13C NMR at 100 MHz)

[0057] 6530 Accurate-Mass Triple quald. LC-MS/MS (Agilent Technologies, Germany)

[0058] All the compounds used for structure analysis were purchased from Sigma Chemical Co. (St. Louis, Mo., USA).

[0059] NMR Structure Analysis

[0060] Hydrogen-related chemical environments were interpreted from chemical shifts on the .sup.1H-NMR spectrum; three-dimensional configurations with neighboring hydrogen atoms were interpreted from coupling constants; the number of hydrogen atoms was identified from integrations; and the number of carbon atoms constituting a compound and neighboring environments of the carbon atoms were interpreted from the .sup.13C-NMR spectrum.

[0061] As can be identified from FIG. 2, the anomer proton signal (δ.sub.H 5.03, d, J=4.0 Hz, H-1) resulting from the sugar, oxygenated methine proton signals shown as a sugar moiety, and oxygenated methylene proton signals (δ.sub.H 3.60-3.99, m, H-2, 3, 4, 5, and 6) were observed in the .sup.1H-NMR spectrum, and this was predicted to be glucose or galactose.

[0062] As can be identified from FIG. 3, the presence of glycerol composed of three carbon atoms, including one molecule of sugar, was identified through a total of nine carbon atoms from the .sup.13C-NMR spectrum. The sugar was identified to be galactose through the anomer carbon signal δ.sub.c 98.03 (C-1) resulting from the sugar, oxygenated methine carbon signals [δc 71.03 (C-5), 69.32 (C-3), 69.21 (C-4) and 68.44 (C-2)] and oxygenated methylene carbon signal δc 61.10 (C-6).

[0063] The presence of glycerol was identified through one oxygenated methine carbon signal δc 78.68 (C-2′) and two oxygenated methylene carbon signals [δc 61.35 (C-1′) and 60.31 (C-3′)]. Therefore, the above-mentioned compound (sample) was identified to have a structure of 2-O-α-D-galactopyranosylglycerol (floridoside).

[0064] As a result of ESI-MS measurement, 253 [M-H].sup.− in the negative mode and 277 [M+Na].sup.+ in the positive mode were observed, indicating a molecular weight of 254.

Test Example 1: Cytotoxicity Test

[0065] A cytotoxicity test was performed on the sample, which had been identified to be floridoside, by using the Cell Counting Kit-8 kit (DOJINDO, CK04-05).

[0066] Raw 264.7 cells were cultured at 1×10.sup.4 cells/well in a DMEM medium containing 10% FBS in a 96-well plate at 37° C. in 5% CO.sub.2 incubator for 24 hours, and then treated with a drug. After the cells were cultured at 37° C. in the 5% CO.sub.2 incubator for 24 hours, CCK-8 solution was added, followed by incubation at 37° C. for 2 hours, and then the absorbance was measured at 450 nm. The results are shown in Table 1 below.

TABLE-US-00001 TABLE 1 Concentration (ppm) Absorbance (nm) AVERAGE Standard deviation Viability (%) Floridoside 1 2.726 2.589 2.466 2.594 0.106 83 10 2.692 2.735 2.810 2.746 0.049 88 100 2.676 2.790 2.810 2.759 0.059 88 500 2.721 2.801 2.849 2.790 0.053 89 1000 2.751 2.769 2.824 2.781 0.031 89 con 3.113 3.1 3.182 3.132 0.036 100

[0067] As can be seen from Table 1, as the floridoside content increased, the viability was also improved. It can be identified from the results that floridoside had an excellent cell protective effect.

Test Example 2: Patch Test

[0068] A primary patch test for human body application was performed on the sample.

[0069] Subjects of the test were determined for skin irritation by a dermatologist a total of 4 times (the date of a patch, the date of removal of the patch, and 24 hours and 120 hours after removal of the patch) during the test period.

[0070] The skin patch test was performed using the Van der Bend chamber (Van der Bend, Brielle, the Netherlands). For each of 31 subjects, the sample was applied between the shoulder blade and the waist line on the basis of the spin on the back by using the Van der Bend chamber.

[0071] A site of the test was washed with distilled water and dried, and then the sample was dissolved in 10% distilled water. Thereafter, 35 μl was dropped in the Van der Bend chamber, which was then put and fixed on the site of the test. The sample was patched on the skin for 48 hours, and after the removal of the patch, the site of the test was marked with a marking pen, and the site of the test was observed after 30 minutes, 24 hours, and 120 hours.

[0072] With respect to the skin reaction, the degrees of irritation were classified according to the evaluation criteria of the International Contact Dermatitis Research Group (ICDRG) as shown in Table 2 below. [89]

TABLE-US-00002 TABLE 2 Symbol Score Skin reaction evaluation criteria − 0 Negative reaction: No irritation ± 0.5 Doubtful or slight Slight or faint reaction: Slight erythema irritation + 1 Weak (non-vesicular) Clear boundary positive reaction: lined but weak Weak irritation erythema, edema, and papule ++ 2 Strong(vesicular) Clear erythema, positive reaction: papule, and small Medium irritation blister +++ 3 Extreme positive Strong erythema reaction: Strong and blister irritation

[0073] The mean score of the skin reaction was calculated by the skin reaction calculation formula, and then the presence or absence of irritation was determined according to the decision table of the skin patch test. The skin patch test results are shown in Table 3.

TABLE-US-00003 TABLE 3 After 30 After 24 After 120 NO minutes hours hours 1 — — — 2 — — — 3 — — — 4 — — — 5 — — — 6 — — — 7 — — — 8 — — — 9 — — — 10 — — — 11 — — — 12 — — — 13 — — — 14 — — — 15 — — — 16 — — — 17 — — — 18 — — — 19 — — — 20 — — — 21 — — — 22 — — — 23 — — — 24 — — — 25 — — — 26 — — — 27 — — — 28 — — — 29 — — — 30 — — — 31 — — — Degree + 0 0 0 of + 0 0 0 reaction ++ 0 0 0 +++ 0 0 0 Mean score 0.00 Determination No irritation

Preparative Example 2: Synthesis of Glycoside Covalent Derivative of Floridoside and Nucleobase

[0074] A purine was bound to the floridoside prepared in Preparative Example 1 by solid phase peptide synthesis using Fmoc. As a result of .sup.1H-NMR spectrum and .sup.13C-NMR spectrum analyses, a glycosidic covalent bond was formed between floridoside and the nucleobase as shown in FIG. 6.

Preparative Example 3: Synthesis of Glycoside Covalent Derivative of Floridoside and Nucleoside

[0075] A ribonucleoside was bound to the floridoside prepared in Preparative Example 1 by solid phase peptide synthesis using Fmoc. As a result of .sup.1H-NMR spectrum and .sup.13C-NMR spectrum analyses, a glycosidic covalent bond was formed between floridoside and the nucleoside as shown in FIG. 7.

Preparative Example 4: Synthesis of Glycoside Covalent Derivative of Floridoside and Amino Acid

[0076] Alanine was bound to the floridoside prepared in Preparative Example 1 by solid phase peptide synthesis using Fmoc. As a result of .sup.1H-NMR spectrum and .sup.13C-NMR spectrum analyses, a glycosidic covalent bond was formed between floridoside and the amino acid as shown in FIGS. 8 and 9.

Example 1

[0077] The glycoside covalent derivative of floridoside and the nucleobase in Preparative Example 2 was diluted in distilled water to prepare a composition having a covalent derivative content of 25 wt % relative to 100 wt % of the total composition.

Example 2

[0078] The glycoside covalent derivative of floridoside and the nucleoside in Preparative Example 3 was diluted in distilled water to prepare a composition having a covalent derivative content of 25 wt % relative to 100 wt % of the total composition.

Example 3

[0079] The glycoside covalent derivative of floridoside and the amino acid in Preparative Example 4 was diluted in distilled water to prepare a composition having a covalent derivative content of 25 wt % relative to 100 wt % of the total composition.

Test Example 3: In Vitro UVA Evaluation Test

[0080] To test UV blocking test of the compositions of Examples 1 to 3, the in vitro UVA evaluation test was performed using a UV spectrophotometer.

[0081] Each of the compositions (1.3 mg/cm.sup.2) of Examples 1 to 3 was well spread on the PMMA plate, dried for 15 minutes, and then placed into the SPF-290AS™ SPF Testing Analyzer System. The UV absorbance at 290-400 nm was measured for 8 points on the plate. The mean value was calculated by repeated measurements using three plates for each composition. SPF (UVB) and PA (UVA) measurement results are shown in Table 4.

TABLE-US-00004 TABLE 4 Number SPF PA Number SPF PA Number SPF PA Example 1 5.3 4.1 Example 1 3.4 2.8 Example 1 2.3 2.1 1 2 5.7 4.5 2 2 3.7 3.2 3 2 2.3 1.9 3 5.6 4.5 3 3.4 2.9 3 2.5 2.0 Mean 5.6 4.4 Mean 3.5 3.0 Mean 2.4 2.0 Standard 0.2 0.2 Standard 0.1 0.2 Standard 0.1 0.1 Deviation Deviation Deviation

[0082] As can be seen from Table 4 and FIGS. 6 to 9, the floridoside according to Examples 1 to 3 exhibited an enhanced UV blocking effect by forming a glycosidic covalent bond with a nucleobase, a nucleoside, or an amino acid.